4:30 PM
 | 
Jan 09, 2017
 |  BC Extra  |  Company News

Allergan in deals with Lysosomal Therapeutics, Assembly

Allergan plc (NYSE:AGN) announced two deals Monday, gaining an exclusive option to acquire neurodegenerative disease company Lysosomal Therapeutics Inc. (Cambridge, Mass.) and a license for rights to four gastrointestinal microbiome programs from Assembly BioSciences Inc. (NASDAQ:ASMB).

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >